Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_17266 | 62 | 1.30 | Mlig455_043650 | Neo: - Age: - |
Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.753 | 1.261 | 1.00000 | 1.00000 | |
RegionR2 | 0.726 | 1.261 | 0.53455 | 0.90488 | |
RegionR3 | 0.531 | 1.261 | 0.48868 | 0.98759 | |
RegionR4 | 1.848 | 1.261 | 0.24960 | 0.54885 | |
RegionR5 | -1.633 | 1.261 | 0.97143 | 1.00000 | |
RegionR6 | -3.783 | 1.261 | 0.99973 | 1.00000 | |
RegionR7 | 1.172 | 1.261 | 0.41243 | 1.00000 | |
RegionR8 | 1.892 | 1.261 | 0.23420 | 0.84897 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.191 | 1.261 | 1.00000 | 1.00000 | |
RegenerationR2 | -0.75 | 1.261 | 0.54729 | 0.89173 | |
RegenerationR3 | -1.866 | 1.261 | 0.23462 | 0.66898 | |
RegenerationR4 | -1.708 | 1.261 | 0.29344 | 0.73674 | |
RegenerationR5 | 3.969 | 1.261 | 0.00984 | 0.17643 | |
RegenerationR6 | 5.528 | 1.261 | 0.00421 | 0.07788 | |
RegenerationBL | 3.015 | 1.261 | 0.03064 | 0.19541 | |
RegenerationTP | -1.398 | 1.261 | 0.41372 | 0.83958 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
2. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 2.601 | 0.826 | 0.998 | 0.777 | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
3. | MligTC455_18171 | 108 | 2.25 | Mlig455_034306, Mlig455_067304, Mlig455_067320 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.816/0.02161 Regeneration-upregulated BL: 6.953 Regeneration-enriched BL: 6.953 |
2.559 | - | 0.778 | 0.986 | 0.795 | - | - | Mlig455_034306 {REF} {Length: 840} {TRANSSPLICED} {RNA1310_58083} {RNA815_58789} Mlig455_067304 {REF} {Length: 733} {TRANSSPLICED} {RNA1310_58083} {RNA815_58789} Mlig455_067320 {REF} {Length: 454} {RNA1310_58083} {RNA815_58789} |
|
4. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 2.556 | 0.795 | 0.791 | 0.970 | - | - | - | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
5. | MligTC455_49094 | 59 | 1.22 | Mlig455_065396 | Neo: - Age: - |
RERGL | 2.547 | 0.877 | 0.701 | 0.969 | - | - | - | Mlig455_065396 {REF} {Length: 1449} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=61.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=25.4]} {Human: ENSG00000111404, RERGL, RERG like, [Score=80.5, Expect=7e-18]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=80.1, Expect=7e-18]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=84.7, Expect=1e-19]} {Dmel: FBgn0035711, CG8519, [Score=69.3, Expect=4e-14]} {Celegans: WBGene00004309, rap-3, RAP homolog (Vertebrate Rap GTPase family), [Score=59.3, Expect=1e-10]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=80.1, Expect=3e-18]} {RNA1509_41924} {RNA1310_34154} {RNA815_43516} |
6. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 1.98 | - | 0.985 | 0.995 | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
7. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.961 | - | 0.982 | 0.979 | - | - | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
8. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 1.961 | - | 0.968 | 0.993 | - | - | - | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
9. | MligTC455_50643 | 38 | 0.8 | Mlig455_007952, Mlig455_008053 | Neo: - Age: - |
VSX1 | 1.943 | - | 0.953 | 0.990 | - | - | - | Mlig455_007952 {REF} {Length: 1358} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} Mlig455_008053 {REF} {Length: 2271} {RNA1310_76393} {RNA815_51313} |
10. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
1.935 | - | 0.968 | 0.967 | - | - | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
11. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.933 | - | 0.994 | 0.939 | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
12. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.919 | - | 0.998 | 0.921 | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
13. | MligTC455_19126 | 10 | 0.2 | Mlig455_009225 | Neo: - Age: - |
1.918 | - | 0.938 | 0.980 | - | - | - | Mlig455_009225 {REF} {Length: 1570} {Pfam: Galactosyltransferase [PF01762.23, score=21.4]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=50.4, Expect=1e-06]} {RNA1310_57689} {RNA815_57743} | |
14. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 1.91 | - | 0.993 | 0.917 | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
15. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 1.908 | - | 0.936 | 0.972 | - | - | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
16. | MligTC455_35503 | 32 | 0.66 | Mlig455_009758, Mlig455_070115 | Neo: - Age: - |
HMX3 | 1.904 | - | 0.911 | 0.993 | - | - | - | Mlig455_009758 {REF} {Length: 2090} {Pfam: Homeodomain [PF00046.31, score=72.3]} {Human: ENSG00000188620, HMX3, H6 family homeobox 3, [RH, Score=163, Expect=1e-44]} {Mouse: ENSMUSG00000040148, Hmx3, H6 homeobox 3, [RH, Score=162, Expect=2e-44]; ENSMUSG00000067438, Hmx1, H6 homeobox 1, [RH, Score=155, Expect=4e-42]} {Dmel: FBgn0011758, B-H1, BarH1, [Score=102, Expect=1e-22]} {Celegans: WBGene00003377, mls-2, Mesodermal Lineage Specification, [RH, Score=113, Expect=2e-27]} {Smed: dd_Smed_v6_52497_0_1, dd_Smed_v6_52497_0_1, [RH, Score=150, Expect=4e-42]} Mlig455_070115 {REF} {Length: 2868} {Pfam: Homeodomain [PF00046.31, score=72.2]} {Human: ENSG00000188620, HMX3, H6 family homeobox 3, [RH, Score=163, Expect=6e-45]} {Mouse: ENSMUSG00000040148, Hmx3, H6 homeobox 3, [RH, Score=162, Expect=1e-44]; ENSMUSG00000067438, Hmx1, H6 homeobox 1, [RH, Score=155, Expect=3e-42]} {Dmel: FBgn0011758, B-H1, BarH1, [Score=102, Expect=9e-23]} {Celegans: WBGene00003377, mls-2, Mesodermal Lineage Specification, [RH, Score=113, Expect=1e-27]} {Smed: dd_Smed_v6_52497_0_1, dd_Smed_v6_52497_0_1, [RH, Score=151, Expect=2e-42]} {RNA1310_148861} |
17. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
1.901 | - | 0.937 | 0.964 | - | - | - | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
18. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
1.895 | - | 0.994 | 0.901 | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
19. | MligTC455_05494 | 51 | 1.06 | Mlig455_004276, Mlig455_004287, Mlig455_004362 | Neo: - Age: - |
1.894 | - | 0.934 | 0.960 | - | - | - | Mlig455_004276 {REF} {Length: 1694} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1310_39315} {RNA815_27280} Mlig455_004287 {REF} {Length: 4218} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1509_28642} {RNA1310_39315} {RNA815_27280} Mlig455_004362 {REF} {Length: 400} {NoTransDecoderORF} {RNA1310_149581} |
|
20. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
1.893 | - | 0.998 | 0.895 | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
21. | MligTC455_23287 | 106 | 2.21 | Mlig455_052789 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.273/0.00029 |
1.888 | - | 0.912 | 0.976 | - | - | - | Mlig455_052789 {REF} {Length: 2348} {RNA1310_41474} {RNA815_41242} | |
22. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
1.88 | - | 0.975 | 0.905 | - | - | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
23. | MligTC455_19412 | 42 | 0.88 | Mlig455_047997 | Neo: - Age: - |
1.879 | - | 0.883 | 0.996 | - | - | - | Mlig455_047997 {REF} {Length: 701} {RNA1310_53549} {RNA815_27051} | |
24. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 1.873 | - | 0.992 | 0.881 | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
25. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 1.872 | - | 0.988 | 0.884 | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
26. | MligTC455_43261 | 41 | 0.86 | Mlig455_065982 | Neo: - Age: - |
1.872 | - | 0.921 | 0.951 | - | - | - | Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
27. | MligTC455_19524 | 100 | 2.09 | Mlig455_010263 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.437/0.01311 |
1.871 | - | 0.900 | 0.971 | - | - | - | Mlig455_010263 {REF} {Length: 2969} {RNA1310_11925.1} {RNA815_27110} | |
28. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 1.87 | - | 0.914 | 0.956 | - | - | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
29. | MligTC455_52480 | 25 | 0.51 | Mlig455_040937 | Neo: - Age: - |
1.862 | - | 0.874 | 0.988 | - | - | - | Mlig455_040937 {REF} {Length: 2050} {RNA1310_86606} {RNA815_50003.1} | |
30. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
1.853 | - | 0.973 | 0.880 | - | - | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
31. | MligTC455_38666 | 17 | 0.35 | Mlig455_057276, Mlig455_059622 | Neo: - Age: - |
WDR17 | 1.842 | - | - | 0.991 | - | 0.851 | - | Mlig455_057276 {REF} {Length: 5936} {Pfam: WD domain, G-beta repeat [PF00400.34, score=120.0]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=72.8]} {Human: ENSG00000150627, WDR17, WD repeat domain 17, [RH, Score=913, Expect=0.0]} {Mouse: ENSMUSG00000039375, Wdr17, WD repeat domain 17, [RH, Score=926, Expect=0.0]} {Dmel: FBgn0263933, ebi, [Score=92.4, Expect=1e-18]} {Celegans: WBGene00004767, sel-10, F-box/WD repeat-containing protein sel-10, [Score=91.7, Expect=1e-18]} {Smed: dd_Smed_v6_3247_0_1, dd_Smed_v6_3247_0_1, [Score=92.4, Expect=5e-19]} {RNA1310_51041} Mlig455_059622 {REF} {Length: 4040} {Pfam: WD domain, G-beta repeat [PF00400.34, score=119.9]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=72.9]} {Human: ENSG00000150627, WDR17, WD repeat domain 17, [RH, Score=915, Expect=0.0]} {Mouse: ENSMUSG00000039375, Wdr17, WD repeat domain 17, [RH, Score=925, Expect=0.0]} {Dmel: FBgn0263933, ebi, [Score=92.4, Expect=1e-18]} {Celegans: WBGene00004767, sel-10, F-box/WD repeat-containing protein sel-10, [Score=92.0, Expect=1e-18]} {Smed: dd_Smed_v6_3247_0_1, dd_Smed_v6_3247_0_1, [Score=92.4, Expect=5e-19]} {RNA1310_127425} |
32. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 1.838 | - | 0.964 | 0.874 | - | - | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
33. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
1.837 | - | 0.959 | 0.878 | - | - | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
34. | MligTC455_25761 | 8 | 0.17 | Mlig455_002214 | Neo: - Age: - |
1.836 | - | - | 0.881 | - | 0.955 | - | Mlig455_002214 {REF} {Length: 2219} {RNA1509_23358} {RNA1310_81622} {RNA815_55072.1} | |
35. | MligTC455_09416 | 15 | 0.32 | Mlig455_025505, Mlig455_025526 | Neo: - Age: - |
HRH1 | 1.834 | - | 0.951 | 0.883 | - | - | - | Mlig455_025505 {REF} {Length: 1843} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=122.8]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [Score=131, Expect=4e-34]} {Mouse: ENSMUSG00000053004, Hrh1, histamine receptor H1, [Score=127, Expect=9e-33]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [Score=113, Expect=2e-27]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=102, Expect=4e-24]} {Smed: dd_Smed_v6_15040_0_1, dd_Smed_v6_15040_0_1, [Score=99.4, Expect=4e-23]} {RNA1509_53354} {RNA1310_79526} {RNA815_31150} Mlig455_025526 {REF} {Length: 2045} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=247.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=30.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.8]; Olfactory receptor [PF13853.8, score=23.3]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [RH, Score=264, Expect=2e-82]} {Mouse: ENSMUSG00000053004, Hrh1, histamine receptor H1, [RH, Score=264, Expect=2e-82]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=192, Expect=2e-54]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=187, Expect=4e-53]} {Smed: dd_Smed_v6_48706_0_1, dd_Smed_v6_48706_0_1, [Score=189, Expect=2e-55]} {RNA1509_53354} {RNA1310_79526} {RNA815_31150} |
36. | MligTC455_01861 | 30 | 0.63 | Mlig455_046027 | Neo: - Age: - |
1.833 | - | 0.950 | 0.883 | - | - | - | Mlig455_046027 {REF} {Length: 736} {RNA1310_50531} {RNA815_29422} | |
37. | MligTC455_24470 | 37 | 0.76 | Mlig455_020119 | Neo: - Age: - |
1.827 | - | 0.847 | 0.980 | - | - | - | Mlig455_020119 {REF} {Length: 1150} {Pfam: Pancreatic hormone peptide [PF00159.20, score=22.9]} {RNA1310_54016} {RNA815_51613} | |
38. | MligTC455_17745 | 196 | 4.09 | Mlig455_004714, Mlig455_064787 | Neo: Int S/G2/M Age: - |
INTS2 | 1.826 | - | - | 0.962 | - | - | 0.864 | Mlig455_004714 {REF} {Length: 4644} {Pfam: Integrator complex subunit 2 [PF14750.8, score=436.5]} {Human: ENSG00000108506, INTS2, integrator complex subunit 2, [RH, Score=244, Expect=3e-65]} {Mouse: ENSMUSG00000018068, Ints2, integrator complex subunit 2, [RH, Score=241, Expect=1e-64]} {Dmel: FBgn0030858, IntS2, Integrator 2, [RH, Score=242, Expect=2e-65]} {Smed: dd_Smed_v6_7197_0_2, dd_Smed_v6_7197_0_2, [RH, Score=330, Expect=5e-95]} {RNA1509_16977} {RNA1310_2572} {RNA815_13711} Mlig455_064787 {REF} {Length: 4667} {Pfam: Integrator complex subunit 2 [PF14750.8, score=434.8]} {Human: ENSG00000108506, INTS2, integrator complex subunit 2, [RH, Score=244, Expect=2e-65]} {Mouse: ENSMUSG00000018068, Ints2, integrator complex subunit 2, [RH, Score=239, Expect=3e-64]} {Dmel: FBgn0030858, IntS2, Integrator 2, [RH, Score=243, Expect=9e-66]} {Smed: dd_Smed_v6_7197_0_2, dd_Smed_v6_7197_0_2, [RH, Score=329, Expect=8e-95]} {RNA1509_16977} {RNA1310_2572} {RNA815_13711} |
39. | MligTC455_32292 | 66 | 1.38 | Mlig455_028882 | Neo: - Age: - Region-enriched R2: 3.876/0.02790 |
GRIK2 | 1.825 | 0.825 | - | 1.000 | - | - | - | Mlig455_028882 {REF} {Length: 3574} {Pfam: Ligand-gated ion channel [PF00060.28, score=188.3]; Receptor family ligand binding region [PF01094.30, score=116.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=103.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=84.0]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=609, Expect=0.0]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=585, Expect=0.0]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=583, Expect=0.0]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=609, Expect=0.0]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=581, Expect=0.0]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=580, Expect=0.0]} {Dmel: FBgn0039927, CG11155, [RH, Score=615, Expect=0.0]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=412, Expect=4e-129]} {Smed: dd_Smed_v6_8816_0_1, dd_Smed_v6_8816_0_1, [Score=471, Expect=1e-149]} {RNA1509_15645} {RNA1310_1989.1, RNA1509_15645} {RNA1509_15645, RNA815_797} |
40. | MligTC455_13505 | 132 | 2.74 | Mlig455_027944 | Neo: - Age: Up-Down-Down |
KCND2 | 1.823 | - | - | 0.951 | 0.872 | - | - | Mlig455_027944 {REF} {Length: 4404} {TRANSSPLICED} {Pfam: Ion transport protein [PF00520.33, score=127.7]; BTB/POZ domain [PF02214.24, score=91.1]; Ion channel [PF07885.18, score=49.3]; Shal-type voltage-gated potassium channels, N-terminal [PF11601.10, score=48.9]; Domain of unknown function (DUF3399) [PF11879.10, score=43.6]; BTB/POZ domain [PF16017.7, score=28.0]} {Human: ENSG00000184408, KCND2, potassium voltage-gated channel subfamily D member 2, [RH, Score=719, Expect=0.0]; ENSG00000171385, KCND3, potassium voltage-gated channel subfamily D member 3, [RH, Score=711, Expect=0.0]; ENSG00000102057, KCND1, potassium voltage-gated channel subfamily D member 1, [RH, Score=691, Expect=0.0]} {Mouse: ENSMUSG00000060882, Kcnd2, potassium voltage-gated channel, Shal-related family, member 2, [RH, Score=716, Expect=0.0]; ENSMUSG00000040896, Kcnd3, potassium voltage-gated channel, Shal-related family, member 3, [RH, Score=712, Expect=0.0]; ENSMUSG00000009731, Kcnd1, potassium voltage-gated channel, Shal-related family, member 1, [RH, Score=694, Expect=0.0]} {Dmel: FBgn0005564, Shal, Shaker cognate l, [RH, Score=747, Expect=0.0]} {Celegans: WBGene00022240, shl-1, SHaL family of potassium channels, [RH, Score=712, Expect=0.0]} {Smed: dd_Smed_v6_15876_0_1, dd_Smed_v6_15876_0_1, [RH, Score=716, Expect=0.0]} {RNA1509_23965} {RNA1310_7319} {RNA815_9248} |
41. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.821 | - | 0.961 | 0.860 | - | - | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
42. | MligTC455_16846 | 158 | 3.3 | Mlig455_051873 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.265/0.00110 |
PRSS33 | 1.816 | - | 0.849 | 0.967 | - | - | - | Mlig455_051873 {REF} {Length: 1386} {Pfam: Trypsin [PF00089.28, score=189.9]; Domain of unknown function (DUF1986) [PF09342.13, score=27.5]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=154, Expect=4e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=125, Expect=2e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=3e-53]} {RNA1509_26566} {RNA1310_23561} {RNA815_9840} |
43. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
1.816 | - | 0.981 | 0.835 | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
44. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 1.815 | - | 0.964 | 0.851 | - | - | - | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
45. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 1.8 | 0.819 | 0.981 | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
46. | MligTC455_43116 | 105 | 2.2 | Mlig455_006245, Mlig455_006299, Mlig455_061192 | Neo: - Age: - |
ESRRB | 1.794 | - | 0.797 | 0.997 | - | - | - | Mlig455_006245 {REF} {Length: 450} {NoTransDecoderORF} Mlig455_006299 {REF} {Length: 2539} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.3]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=20.3]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=94.4, Expect=2e-20]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=88.2, Expect=1e-18]; ENSMUSG00000024955, Esrra, estrogen related receptor, alpha, [Score=86.7, Expect=3e-18]; ENSMUSG00000015846, Rxra, retinoid X receptor alpha, [Score=85.1, Expect=1e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=84.7, Expect=2e-17]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.9, Expect=3e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_86523} Mlig455_061192 {REF} {Length: 2120} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.2]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=19.6]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=97.4, Expect=2e-21]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.1, Expect=4e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_13691_0_1, dd_Smed_v6_13691_0_1, [Score=79.7, Expect=1e-16]} {RNA1310_86523} |
47. | MligTC455_29798 | 4280 | 89.16 | Mlig455_061171 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.579 Region-enriched R2: 6.440/0.00000 |
1.79 | - | 0.838 | 0.952 | - | - | - | Mlig455_061171 {REF} {Length: 688} {RNA1509_23190} {RNA1310_44752} {RNA815_21540} | |
48. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 1.789 | - | 0.833 | 0.956 | - | - | - | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
49. | MligTC455_40905 | 53 | 1.1 | Mlig455_002794, Mlig455_002809 | Neo: - Age: - |
CHL1 | 1.789 | - | - | 0.955 | 0.834 | - | - | Mlig455_002794 {REF} {Length: 4845} {Pfam: Immunoglobulin domain [PF13927.8, score=205.6]; Immunoglobulin I-set domain [PF07679.18, score=151.2]; Immunoglobulin domain [PF00047.27, score=122.8]; Immunoglobulin domain [PF13895.8, score=109.6]; Fibronectin type III domain [PF00041.23, score=98.8]; Immunoglobulin V-set domain [PF07686.19, score=65.4]; Immunoglobulin domain [PF18452.3, score=21.7]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [RH, Score=340, Expect=1e-96]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [RH, Score=339, Expect=2e-96]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [RH, Score=335, Expect=4e-95]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=358, Expect=2e-103]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=287, Expect=1e-79]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=486, Expect=3e-148]} {RNA1310_42673} Mlig455_002809 {REF} {Length: 4785} {Pfam: Immunoglobulin domain [PF13927.8, score=155.8]; Immunoglobulin I-set domain [PF07679.18, score=111.7]; Fibronectin type III domain [PF00041.23, score=99.0]; Immunoglobulin domain [PF00047.27, score=90.9]; Immunoglobulin domain [PF13895.8, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=38.0]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [Score=292, Expect=8e-81]; ENSG00000163531, NFASC, neurofascin, [Score=290, Expect=4e-80]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [Score=294, Expect=2e-81]; ENSMUSG00000026442, Nfasc, neurofascin, [Score=290, Expect=2e-80]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [Score=285, Expect=2e-78]; ENSMUSG00000020598, Nrcam, neuronal cell adhesion molecule, [Score=282, Expect=7e-78]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=315, Expect=1e-88]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=251, Expect=9e-68]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=441, Expect=4e-132]} {RNA1310_42673} |
50. | MligTC455_13434 | 15 | 0.3 | Mlig455_025922 | Neo: - Age: - |
1.785 | - | 0.797 | 0.988 | - | - | - | Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338} | |
51. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 1.781 | - | 0.806 | 0.975 | - | - | - | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
52. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 1.777 | - | 0.987 | 0.790 | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
53. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
1.777 | - | 0.982 | 0.795 | - | - | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
54. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
1.768 | - | 0.998 | 0.770 | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
55. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
1.763 | - | 0.998 | 0.765 | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
56. | MligTC455_12294 | 25 | 0.53 | Mlig455_042579 | Neo: - Age: - |
1.761 | - | - | 0.957 | - | 0.804 | - | Mlig455_042579 {REF} {Length: 435} {NoTransDecoderORF} {RNA1310_80647} | |
57. | MligTC455_36374 | 58 | 1.2 | Mlig455_016115 | Neo: - Age: - |
1.761 | 0.800 | - | 0.961 | - | - | - | Mlig455_016115 {REF} {Length: 4900} {RNA1509_18263} {RNA1310_1232} {RNA815_347} | |
58. | MligTC455_47544 | 42 | 0.88 | Mlig455_055595, Mlig455_055624 | Neo: - Age: - |
RASL10B | 1.758 | - | 0.965 | 0.793 | - | - | - | Mlig455_055595 {REF} {Length: 1887} {Pfam: Ras family [PF00071.24, score=75.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=34.0]; AAA ATPase domain [PF13191.8, score=20.2]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=151, Expect=2e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=151, Expect=2e-44]} {Dmel: FBgn0037326, CG14669, [Score=112, Expect=1e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=54.7, Expect=7e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} Mlig455_055624 {REF} {Length: 1840} {Pfam: Ras family [PF00071.24, score=74.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=33.3]; AAA ATPase domain [PF13191.8, score=19.8]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=150, Expect=4e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=152, Expect=6e-45]} {Dmel: FBgn0037326, CG14669, [Score=111, Expect=2e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} |
59. | MligTC455_06448 | 13 | 0.26 | Mlig455_022314, Mlig455_069882 | Neo: - Age: - |
1.754 | - | 0.754 | 1.000 | - | - | - | Mlig455_022314 {REF} {Length: 354} {Pfam: Pancreatic hormone peptide [PF00159.20, score=26.8]} {RNA1310_54016} {RNA815_51613} Mlig455_069882 {REF} {Length: 365} {Pfam: Pancreatic hormone peptide [PF00159.20, score=29.8]} {RNA1310_54016} {RNA815_51613} |
|
60. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.749 | - | 0.759 | 0.990 | - | - | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
61. | MligTC455_24405 | 48 | 0.99 | Mlig455_027683 | Neo: - |
1.749 | 0.771 | - | 0.978 | - | - | - | Mlig455_027683 {REF} {Length: 2258} {RNA1310_62452} {RNA815_35919} | |
62. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 1.749 | - | 0.979 | 0.770 | - | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
63. | MligTC455_31685 | 83 | 1.73 | Mlig455_036333, Mlig455_036334, Mlig455_036356, Mlig455_054550 | Neo: - Age: - |
SLC5A7 | 1.745 | - | 0.750 | 0.995 | - | - | - | Mlig455_036333 {REF} {Length: 491} {tRNA: Ala(CGC),pseudo, score=26.8} {RNA1509_45595} {RNA1310_13430.1} {RNA815_31014} Mlig455_036334 {REF} {Length: 599} {NoTransDecoderORF} {RNA1310_51434} {RNA815_35996} Mlig455_036356 {REF} {Length: 4094} {tRNA: Ala(CGC),pseudo, score=26.8} {Pfam: Sodium:solute symporter family [PF00474.19, score=114.3]} {Human: ENSG00000115665, SLC5A7, solute carrier family 5 member 7, [RH, Score=591, Expect=0.0]} {Mouse: ENSMUSG00000023945, Slc5a7, solute carrier family 5 (choline transporter), member 7, [RH, Score=595, Expect=0.0]} {Dmel: FBgn0038641, CG7708, [RH, Score=602, Expect=0.0]} {Celegans: WBGene00000501, cho-1, High-affinity choline transporter 1, [RH, Score=553, Expect=0.0]} {Smed: dd_Smed_v6_12883_0_1, dd_Smed_v6_12883_0_1, [RH, Score=649, Expect=0.0]} {RNA1509_56795} {RNA1310_15022.1} {RNA815_33275} Mlig455_054550 {REF} {Length: 303} {NoTransDecoderORF} {RNA1509_46688} {RNA1310_146263} {RNA815_62938} |
64. | MligTC455_12035 | 25 | 0.53 | Mlig455_058255, Mlig455_058270 | Neo: - Age: Up-Down-Down |
GRIN2A | 1.737 | - | - | 0.980 | - | - | 0.757 | Mlig455_058255 {REF} {Length: 3970} {Pfam: Ligand-gated ion channel [PF00060.28, score=100.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=79.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=71.8]; Receptor family ligand binding region [PF01094.30, score=21.2]} {Human: ENSG00000183454, GRIN2A, glutamate ionotropic receptor NMDA type subunit 2A, [RH, Score=346, Expect=5e-100]; ENSG00000161509, GRIN2C, glutamate ionotropic receptor NMDA type subunit 2C, [RH, Score=343, Expect=4e-101]; ENSG00000273079, GRIN2B, glutamate ionotropic receptor NMDA type subunit 2B, [RH, Score=338, Expect=6e-96]; ENSG00000105464, GRIN2D, glutamate ionotropic receptor NMDA type subunit 2D, [RH, Score=332, Expect=5e-94]} {Mouse: ENSMUSG00000059003, Grin2a, glutamate receptor, ionotropic, NMDA2A (epsilon 1), [RH, Score=347, Expect=6e-99]; ENSMUSG00000020734, Grin2c, glutamate receptor, ionotropic, NMDA2C (epsilon 3), [RH, Score=341, Expect=5e-98]; ENSMUSG00000030209, Grin2b, glutamate receptor, ionotropic, NMDA2B (epsilon 2), [RH, Score=341, Expect=7e-97]; ENSMUSG00000002771, Grin2d, glutamate receptor, ionotropic, NMDA2D (epsilon 4), [RH, Score=331, Expect=4e-94]} {Dmel: FBgn0053513, Nmdar2, NMDA receptor 2, [RH, Score=532, Expect=2e-169]} {Celegans: WBGene00003775, nmr-2, NMDA class glutamate Receptor; NMDA-type ionotropic glutamate receptor NMR-2, [RH, Score=459, Expect=5e-143]} {Smed: dd_Smed_v6_19886_0_1, dd_Smed_v6_19886_0_1, [RH, Score=872, Expect=0.0]} {RNA1509_56620} {RNA1310_18260} {RNA815_11857} Mlig455_058270 {REF} {Length: 4037} {Pfam: Ligand-gated ion channel [PF00060.28, score=99.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=79.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=71.9]; Receptor family ligand binding region [PF01094.30, score=21.3]} {Human: ENSG00000183454, GRIN2A, glutamate ionotropic receptor NMDA type subunit 2A, [RH, Score=347, Expect=9e-99]; ENSG00000161509, GRIN2C, glutamate ionotropic receptor NMDA type subunit 2C, [RH, Score=343, Expect=4e-101]; ENSG00000273079, GRIN2B, glutamate ionotropic receptor NMDA type subunit 2B, [RH, Score=338, Expect=1e-95]; ENSG00000105464, GRIN2D, glutamate ionotropic receptor NMDA type subunit 2D, [RH, Score=330, Expect=1e-93]} {Mouse: ENSMUSG00000059003, Grin2a, glutamate receptor, ionotropic, NMDA2A (epsilon 1), [RH, Score=347, Expect=4e-99]; ENSMUSG00000020734, Grin2c, glutamate receptor, ionotropic, NMDA2C (epsilon 3), [RH, Score=343, Expect=2e-98]; ENSMUSG00000030209, Grin2b, glutamate receptor, ionotropic, NMDA2B (epsilon 2), [RH, Score=339, Expect=2e-96]; ENSMUSG00000002771, Grin2d, glutamate receptor, ionotropic, NMDA2D (epsilon 4), [RH, Score=331, Expect=5e-94]} {Dmel: FBgn0053513, Nmdar2, NMDA receptor 2, [RH, Score=530, Expect=2e-168]} {Celegans: WBGene00003775, nmr-2, NMDA class glutamate Receptor; NMDA-type ionotropic glutamate receptor NMR-2, [RH, Score=461, Expect=8e-144]} {Smed: dd_Smed_v6_11481_0_1, dd_Smed_v6_11481_0_1, [RH, Score=871, Expect=0.0]} {RNA1509_56620} {RNA1310_18260, RNA1509_56620} {RNA1509_56620, RNA815_11857} |
65. | MligTC455_51356 | 297 | 6.18 | Mlig455_002800, Mlig455_002813 | Neo: - Age: logFC(26M/2M)=-0.335 Regeneration-upregulated BL: 4.447 Regeneration-enriched BL: 4.447 |
ARNTL | 1.727 | 0.759 | - | - | 0.968 | - | - | Mlig455_002800 {REF} {Length: 4003} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=41.7]; PAS domain [PF14598.8, score=32.2]; PAS fold [PF08447.14, score=26.1]} {Human: ENSG00000133794, ARNTL, aryl hydrocarbon receptor nuclear translocator like, [Score=174, Expect=4e-46]} {Mouse: ENSMUSG00000055116, Arntl, aryl hydrocarbon receptor nuclear translocator-like, [Score=175, Expect=2e-46]} {Dmel: FBgn0023094, cyc, cycle, [Score=147, Expect=2e-38]} {Celegans: WBGene00000095, aha-1, Aryl hydrocarbon receptor nuclear translocator homolog, [Score=117, Expect=8e-28]} {Smed: dd_Smed_v6_9171_0_1, dd_Smed_v6_9171_0_1, [Score=107, Expect=5e-24]} {RNA1509_21517} {RNA1310_20501.1} {RNA815_14602} Mlig455_002813 {REF} {Length: 3183} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=41.7]; PAS fold [PF08447.14, score=26.6]; PAS domain [PF14598.8, score=26.0]} {Human: ENSG00000133794, ARNTL, aryl hydrocarbon receptor nuclear translocator like, [Score=172, Expect=6e-45]} {Mouse: ENSMUSG00000055116, Arntl, aryl hydrocarbon receptor nuclear translocator-like, [Score=172, Expect=2e-45]} {Dmel: FBgn0023094, cyc, cycle, [Score=146, Expect=6e-38]} {Celegans: WBGene00000095, aha-1, Aryl hydrocarbon receptor nuclear translocator homolog, [Score=116, Expect=2e-27]} {Smed: dd_Smed_v6_9171_0_1, dd_Smed_v6_9171_0_1, [Score=110, Expect=7e-25]} {RNA1509_21517} {RNA1310_20501.1} {RNA815_14602} |
66. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 1.721 | - | 0.981 | 0.740 | - | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
67. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 1.721 | - | 0.998 | 0.723 | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
68. | MligTC455_16672 | 41 | 0.86 | Mlig455_019194 | Neo: - Age: - Region-enriched R2: 5.301/0.02053 |
1.718 | - | 0.737 | 0.981 | - | - | - | Mlig455_019194 {REF} {Length: 648} {RNA1310_52751} {RNA815_26203} | |
69. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
1.717 | - | 0.994 | 0.723 | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
70. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
1.714 | - | 0.983 | 0.731 | - | - | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
71. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.713 | - | 0.990 | 0.723 | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
72. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.713 | - | 0.990 | 0.723 | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
73. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.709 | - | 0.986 | 0.723 | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
74. | MligTC455_12152 | 19 | 0.39 | Mlig455_066811 | Neo: - Age: - |
GPRIN2 | 1.703 | - | 0.745 | 0.958 | - | - | - | Mlig455_066811 {REF} {Length: 1594} {Pfam: G protein-regulated inducer of neurite outgrowth C-terminus [PF15235.8, score=49.2]} {Human: ENSG00000204175, GPRIN2, G protein regulated inducer of neurite outgrowth 2, [RH, Score=55.8, Expect=1e-07]} {Mouse: ENSMUSG00000071531, Gprin2, G protein regulated inducer of neurite outgrowth 2, [RH, Score=53.9, Expect=2e-07]; ENSMUSG00000069227, Gprin1, G protein-regulated inducer of neurite outgrowth 1, [RH, Score=53.9, Expect=3e-07]; ENSMUSG00000045441, Gprin3, GPRIN family member 3, [RH, Score=52.0, Expect=1e-06]} {Smed: dd_Smed_v6_10294_0_1, dd_Smed_v6_10294_0_1, [RH, Score=87.8, Expect=2e-18]} {RNA1310_92598} {RNA815_63284} |
75. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
1.702 | - | 0.979 | 0.723 | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
76. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
1.697 | - | 0.996 | 0.701 | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
77. | MligTC455_12607 | 22 | 0.46 | Mlig455_022861 | Neo: - Age: - |
1.692 | - | 0.969 | 0.723 | - | - | - | Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283} | |
78. | MligTC455_20757 | 286 | 5.96 | Mlig455_005125, Mlig455_005185 | Neo: - Age: - |
1.689 | - | 0.953 | 0.736 | - | - | - | Mlig455_005125 {REF} {Length: 1290} {RNA1310_29676.2} {RNA815_31533} Mlig455_005185 {REF} {Length: 1357} {RNA1310_29676.1} {RNA815_31533} |
|
79. | MligTC455_30495 | 7279 | 151.64 | Mlig455_057847 | Neo: - Age: - Regeneration-upregulated BL: 1.661 Regeneration-enriched BL: 1.661 |
1.684 | - | - | 0.718 | 0.966 | - | - | Mlig455_057847 {REF} {Length: 1211} {RNA1509_23257} {RNA1310_55514} {RNA815_20637} | |
80. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 1.684 | - | 0.728 | 0.956 | - | - | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
81. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
1.684 | - | 0.707 | 0.977 | - | - | - | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
82. | MligTC455_12377 | 14 | 0.29 | Mlig455_022784 | Neo: - Age: - |
1.676 | - | 0.953 | 0.723 | - | - | - | Mlig455_022784 {REF} {Length: 1064} {RNA1310_136157} | |
83. | MligTC455_47110 | 34 | 0.7 | Mlig455_025028 | Neo: - Age: - |
1.676 | - | 0.957 | 0.719 | - | - | - | Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
84. | MligTC455_44862 | 1318 | 27.47 | Mlig455_028792 | Neo: - Age: - Region-enriched R2: 3.389/0.00000 |
QPCT | 1.674 | - | 0.716 | 0.958 | - | - | - | Mlig455_028792 {REF} {Length: 1901} {Pfam: Peptidase family M28 [PF04389.19, score=137.7]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [RH, Score=189, Expect=5e-57]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [RH, Score=190, Expect=3e-57]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [RH, Score=189, Expect=5e-57]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [RH, Score=210, Expect=2e-65]} {Celegans: WBGene00010418, H27A22.1, [Score=182, Expect=5e-55]} {Smed: dd_Smed_v6_4861_0_2, dd_Smed_v6_4861_0_2, [Score=166, Expect=1e-48]} {RNA1509_15042, RNA1509_18145} {RNA1310_21749, RNA1509_15042, RNA1509_18145} {RNA1509_15042, RNA1509_18145, RNA815_8635.1} |
85. | MligTC455_11315 | 154 | 3.2 | Mlig455_027636, Mlig455_027650, Mlig455_036368, Mlig455_069999 | Neo: - Age: - |
1.662 | - | - | 0.957 | 0.705 | - | - | Mlig455_027636 {REF} {Length: 1407} {RNA1509_40399} {RNA1310_60387} {RNA815_44351} Mlig455_027650 {REF} {Length: 1408} {RNA1509_40399} {RNA1310_60387} {RNA815_44351} Mlig455_036368 {REF} {Length: 592} {RNA1310_60387} {RNA815_44351} Mlig455_069999 {REF} {Length: 998} {RNA1310_60387} {RNA815_44351} |
|
86. | MligTC455_03911 | 195 | 4.07 | Mlig455_016862, Mlig455_065907, Mlig455_070025 | Neo: - Age: Up-Down-Down |
ARRB2 | 1.66 | - | 0.705 | 0.955 | - | - | - | Mlig455_016862 {REF} {Length: 658} {NoTransDecoderORF} {RNA1310_129767} {RNA815_58989} Mlig455_065907 {REF} {Length: 4881} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=97.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=81.1]} {Human: ENSG00000141480, ARRB2, arrestin beta 2, [RH, Score=463, Expect=9e-162]} {Mouse: ENSMUSG00000060216, Arrb2, arrestin, beta 2, [RH, Score=461, Expect=5e-161]} {Dmel: FBgn0040206, krz, kurtz, [Score=462, Expect=7e-161]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [RH, Score=469, Expect=4e-164]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=556, Expect=0.0]} {RNA1310_37964.1} {RNA815_56030} Mlig455_070025 {REF} {Length: 4243} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=98.7]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=81.1]} {Human: ENSG00000141480, ARRB2, arrestin beta 2, [RH, Score=464, Expect=3e-162]} {Mouse: ENSMUSG00000060216, Arrb2, arrestin, beta 2, [RH, Score=462, Expect=2e-161]} {Dmel: FBgn0040206, krz, kurtz, [RH, Score=464, Expect=1e-161]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [RH, Score=471, Expect=1e-164]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=558, Expect=0.0]} {RNA1310_37964.1} {RNA815_56030} |
87. | MligTC455_00282 | 64 | 1.34 | Mlig455_011958 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_011958 {REF} {Length: 258} {NoTransDecoderORF} | |
88. | MligTC455_02553 | 40 | 0.83 | Mlig455_057382, Mlig455_057405 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.891/0.03381 |
1 | - | - | 1.000 | - | - | - | Mlig455_057382 {REF} {Length: 445} {NoTransDecoderORF} {RNA1310_52629} Mlig455_057405 {REF} {Length: 4885} {TRANSSPLICED} {Celegans: WBGene00012980, efhd-1, EF HanD calcium binding protein, [Score=46.2, Expect=8e-06]} {RNA1310_42652} {RNA815_37610} |
|
89. | MligTC455_04269 | 11 | 0.23 | Mlig455_060972 | Neo: - Age: - |
HRH3 | 1 | - | - | 1.000 | - | - | - | Mlig455_060972 {REF} {Length: 2387} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.8]; Olfactory receptor [PF13853.8, score=28.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.1]; Domain of unknown function (DUF3413) [PF11893.10, score=22.0]} {Human: ENSG00000101180, HRH3, histamine receptor H3, [Score=77.8, Expect=4e-15]; ENSG00000113749, HRH2, histamine receptor H2, [Score=76.6, Expect=1e-14]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=77.4, Expect=5e-15]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [Score=71.2, Expect=6e-13]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [Score=72.4, Expect=2e-13]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [Score=71.2, Expect=3e-13]} {RNA1310_60530.2} {RNA815_47633} |
90. | MligTC455_06200 | 8 | 0.17 | Mlig455_022367 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_022367 {REF} {Length: 738} {Pfam: WSC domain [PF01822.21, score=44.0]; PAN domain [PF00024.28, score=20.8]} {RNA1310_89673} {RNA815_64813} | |
91. | MligTC455_08518 | 6 | 0.12 | Mlig455_011791 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_011791 {REF} {Length: 905} {Pfam: Lectin C-type domain [PF00059.23, score=27.5]} {Mouse: ENSMUSG00000008874, Clec3a, C-type lectin domain family 3, member a, [Score=46.6, Expect=6e-06]} {RNA1509_20946} {RNA1310_57972} {RNA815_39424} | |
92. | MligTC455_09758 | 74 | 1.55 | Mlig455_022290 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_022290 {REF} {Length: 1401} {RNA1509_44223} {RNA1310_54802} {RNA815_22126} | |
93. | MligTC455_09877 | 4 | 0.08 | Mlig455_062683 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_062683 {REF} {Length: 2060} {RNA1310_74180.2} {RNA815_61774} | |
94. | MligTC455_13123 | 6 | 0.12 | Mlig455_061115 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_061115 {REF} {Length: 2302} {Pfam: PAN domain [PF00024.28, score=19.6]} {RNA1509_16100} {RNA1310_39798} {RNA815_59357} | |
95. | MligTC455_13545 | 8 | 0.17 | Mlig455_053118 | Neo: - Age: - |
ZAN | 1 | - | - | 1.000 | - | - | - | Mlig455_053118 {REF} {Length: 2962} {Pfam: Glycine rich protein [PF12810.9, score=18.9]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=69.7, Expect=1e-11]} {Dmel: FBgn0052834, CG32834, [Score=66.6, Expect=4e-11]} {Celegans: WBGene00004996, spp-11, Saposin-like protein 11, [Score=50.4, Expect=3e-06]} {RNA1310_57796.1} {RNA815_27813} |
96. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
97. | MligTC455_18319 | 68 | 1.42 | Mlig455_033078 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_033078 {REF} {Length: 3408} {Pfam: Leucine rich repeat [PF13855.8, score=25.1]} {RNA1509_58507} {RNA1310_56511} {RNA815_53024} | |
98. | MligTC455_19232 | 31 | 0.65 | Mlig455_059817, Mlig455_061500 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_059817 {REF} {Length: 1369} {RNA1310_23693} {RNA815_52682} Mlig455_061500 {REF} {Length: 1202} {RNA1310_23693} {RNA815_52682} |
|
99. | MligTC455_19546 | 18 | 0.37 | Mlig455_053800 | Neo: - Age: - |
CUBN | 1 | - | - | 1.000 | - | - | - | Mlig455_053800 {REF} {Length: 3139} {Pfam: CUB domain [PF00431.22, score=96.2]} {Human: ENSG00000107611, CUBN, cubilin, [Score=65.5, Expect=3e-10]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=65.1, Expect=3e-10]} {Dmel: FBgn0261262, CG42613, [Score=93.2, Expect=2e-19]} {Celegans: WBGene00010587, sol-2, SOL-2 protein; Suppressor Of Lurcher movement defect, [Score=106, Expect=3e-24]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=73.6, Expect=2e-13]} {RNA1310_54691} |
100. | MligTC455_21608 | 9 | 0.18 | Mlig455_011723 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_011723 {REF} {Length: 501} {NoTransDecoderORF} {RNA1509_38266} {RNA1310_19274} {RNA815_45710} |